The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
Article in Journal of Medical Economics (July 2022)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Aripiprazole in Meige Syndrome: Clinical Response and Implications for Treatment Development.
Article in Clinical Neuropharmacology (August 2021)
Cost of peripheral facial palsy treatment with Botulinum Toxin type A
Article in Journal of Plastic Reconstructive & Aesthetic Surgery (June 2021)